Solifenacin "Mylan" 10 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

solifenacin "mylan" 10 mg filmovertrukne tabletter

mylan ab - solifenacinsuccinat - filmovertrukne tabletter - 10 mg

Solifenacin "Mylan" 5 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

solifenacin "mylan" 5 mg filmovertrukne tabletter

mylan ab - solifenacinsuccinat - filmovertrukne tabletter - 5 mg

Methylphenidate "Mylan" 27 mg depottabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

methylphenidate "mylan" 27 mg depottabletter

mylan ab - methylphenidathydrochlorid - depottabletter - 27 mg

Methylphenidate "Mylan" 36 mg depottabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

methylphenidate "mylan" 36 mg depottabletter

mylan ab - methylphenidathydrochlorid - depottabletter - 36 mg

Methylphenidate "Mylan" 54 mg depottabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

methylphenidate "mylan" 54 mg depottabletter

mylan ab - methylphenidathydrochlorid - depottabletter - 54 mg

Modafinil "Mylan" 100 mg tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

modafinil "mylan" 100 mg tabletter

mylan ab - modafinil - tabletter - 100 mg

Enalapril/Hydrochlorothiazide "Mylan" 20+12,5 mg tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

enalapril/hydrochlorothiazide "mylan" 20+12,5 mg tabletter

mylan ab - enalaprilmaleat, hydrochlorthiazid - tabletter - 20+12,5 mg

Sutent Den Europæiske Union - dansk - EMA (European Medicines Agency)

sutent

pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiske midler - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.

Qinlock Den Europæiske Union - dansk - EMA (European Medicines Agency)

qinlock

deciphera pharmaceuticals (netherlands) b.v. - ripretinib - gastrointestinale stromale tumorer - antineoplastiske midler - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.

Quetiapine "Teva" 100 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

quetiapine "teva" 100 mg filmovertrukne tabletter

teva b.v. - quetiapin fumarat - filmovertrukne tabletter - 100 mg